Minh Tung Phung

Has grant

Assistant Professor

University of Wisconsin-Madison
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Frailty Trajectories and Racial/Ethnic Disparities in Survival among Older Ovarian Cancer Patients

Open Date: 2025-03-01

Close Date: 2026-02-01

Grant: Close

Ovarian cancer treatment outcomes by frailty status

Open Date: 2025-02-01

Close Date: 2026-01-01

Grant: Close

Optimizing a Risk Stratification Model for Ovarian Cancer

Open Date: 2024-04-01

Close Date: 2026-03-01

Grant: Close

Risk-reducing Salpingectomy for Ovarian Cancer Precision Prevention

Open Date: 2024-01-01

Close Date: 2026-01-01

Grant: Close

Early onset breast cancer and research on the environment

Open Date: 2022-07-01

Close Date: 2024-06-30

Articles (11)

Year:

2026

With evidence that salpingectomy is effective in preventing high-grade serous carcinoma, it is time to consider offering this procedure to people at higher-than-average lifetime risk for ovarian cancer, despite not having a pathogenic genetic variant that increases the risk for ovarian cancer. This targeted approach has potential to be effective at reducing ovarian cancer incidence, and unlike opportunistic salpingectomy, it is focused on people with an increased lifetime risk of ovarian cancer. However, the acceptability of this approach within the population of potential patients remains unknown. We conducted an online survey of adults in British Columbia, Canada, who were defined as “at risk” for ovarian cancer (i.e., people born with ovaries). Participants completed a questionnaire on demographics, ovarian cancer risk and protective factors, concerns about risk-reducing salpingectomy (RSS), and the risk they considered high enough to warrant RRS. We included 211 participants. Among these participants, 42% (n = 88) indicated that they would consider RRS at any lifetime risk or any risk above the population average. Another 20 participants chose risks between 1.5% and 4% for a cumulative 51% of the sample choosing risks below thresholds for oophorectomy. In contrast, 6% (n = 12) indicated that they would not consider the procedure at any risk level. None of the factors collected were associated with the likelihood that a person would find RRS acceptable. Overall, our participants showed broad interest in RRS as an ovarian cancer prevention strategy. These results suggest that there would likely be uptake if RRS was offered. Significance: This study found that many participants were willing to consider RRS to prevent ovarian cancer. Further research on RRS should be undertaken to understand how this can be best used for ovarian cancer prevention.

Year:

2025

Supplementary Table 1. Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when lifetime risk is less than 4% compared to greater or equal to 4%, using complete case analysis

Year:

2025

With evidence that salpingectomy is effective in preventing high-grade serous carcinoma, it is time to consider offering this procedure to people at higher-than-average lifetime risk for ovarian cancer, despite not having a pathogenic genetic variant that increases the risk for ovarian cancer. This targeted approach has potential to be effective at reducing ovarian cancer incidence, and unlike opportunistic salpingectomy, it is focused on people with an increased lifetime risk of ovarian cancer. However, the acceptability of this approach within the population of potential patients remains unknown. We conducted an online survey of adults in British Columbia, Canada, who were defined as “at risk” for ovarian cancer (i.e., people born with ovaries). Participants completed a questionnaire on demographics, ovarian cancer risk and protective factors, concerns about risk-reducing salpingectomy (RSS), and the risk they considered high enough to warrant RRS. We included 211 participants. Among these participants, 42% ( n = 88) indicated that they would consider RRS at any lifetime risk or any risk above the population average. Another 20 participants chose risks between 1.5% and 4% for a cumulative 51% of the sample choosing risks below thresholds for oophorectomy. In contrast, 6% ( n = 12) indicated that they would not consider the procedure at any risk level. None of the factors collected were associated with the likelihood that a person would find RRS acceptable. Overall, our participants showed broad interest in RRS as an ovarian cancer prevention strategy. These results suggest that there would likely be uptake if RRS was offered. Significance: This study found that many participants were willing to consider RRS to prevent ovarian cancer. Further research on RRS should be undertaken to understand how this can be best used for ovarian cancer prevention.

Year:

2025

Supplementary Table 1. Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when lifetime risk is less than 4% compared to greater or equal to 4%, using complete case analysis

Year:

2025

Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when the lifetime risk is less than 4%, compared with greater than or equal to 4%, using hot deck imputation

Year:

2025

Year:

2024

Among Arab-American women in Michigan, rates of cervical cancer screening are lower than those in non-Hispanic White and Black women in the state. A deep understanding of the Arab community’s perspective on cervical cancer screening is needed to address the disparity in rates across populations in Michigan. Arab and Chaldean women across Michigan were invited to participate in Zoom-based focus groups to understand the attitudes, acceptability, and barriers of cervical cancer screening among this population. Four focus groups with a total of 19 women aged 30 to 61 were conducted. The focus groups were conducted in English, Arabic, or both languages. The guided discussion was focused on knowledge of cervical cancer and Human papillomavirus (HPV) and its transmission, attitudes towards HPV vaccination, and attitudes towards cervical cancer screening. HPV self-sampling as an alternative to traditional provider-based screening was specifically discussed as this has been proposed as a way to increase screening in hard-to-reach populations. The conversations revealed insights related to barriers at the individual and community levels for screening and vaccination, attitudes towards preventive health care including screening, a need for accessible women’s health literature, and health education. The women also discussed vaccine hesitancy related to HPV and COVID-19, suggesting a need for targeted community interventions.

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Britton Trabert

Associate Professor

University of Utah

UNITED STATES
View details

Maria Jose Garcia

Instituto de Investigaciones Biomédicas Alberto Sols

SPAIN
View details

Jihyoun Jeon

University of Michigan

UNITED STATES
View details

Hui Shen

Van Andel Institute

UNITED STATES
View details

Karen McLean

Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Rafael Meza

Distinguished Scientist

University of Michigan

UNITED STATES
View details

Gillian Hanley

Associate Professory

The University of British Columbia

CANADA
View details

Alice Lee

Associate Professor

California State University Fullerton

UNITED STATES
View details

Hoda Anton-Culver

Professor and Chair

University of California, Irvine

UNITED STATES
View details

David G. Huntsman

The University of British Columbia

CANADA
View details

Fuchsia Howard

Associate Professor

The University of British Columbia

CANADA
View details

Susan Ramus

Professor of Molecular Oncology

University of New South Wales

AUSTRALIA
View details